NCT01604395

Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children

An Open, Multi-center, Prospective and Retrospective Observational Study to Evaluate the Long-term Safety and Effectiveness of Growth Hormone (Eutropin Inj. / Eutropin Plus Inj.) Treatment With GHD, TS, CRF, SGA, ISS and PWS in Children

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 6,000 (estimated)
• Sponsor: LG Chem · Industry
• Sex: All
• Age: 2 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the long-term safety and effectiveness of growth hormone (Eutropin Inj./Eutropin plus Inj.) treatment with GHD (Growth Hormone Deficiency), TS (Turner Syndrome),CRF (Chronic Renal Failure), SGA (Small for Gestational Age), and ISS (Idiopathic Short Stature).

Conditions

• Growth Hormone Deficiency
• Turner Syndrome
• Chronic Renal Failure
• Small for Gestational Age
• Idiopathic Short Stature

Timeline

• Start date: 2012-01-01
• Primary completion: 2032-12-31
• Completion: 2032-12-31
• First posted: 2012-05-23
• Last updated: 2021-02-21

Locations

1 site across 1 country: South Korea